STYK1 |
Q6J9G0
|
serine/threonine/tyrosine kinase 1
|
Kinase
|
9.1E-11 |
0.670 |
0.346 |
MAPK12 |
P53778
|
mitogen-activated protein kinase 12
|
Kinase
|
5.9E-07 |
0.695 |
0.346 |
PFKP |
Q01813
|
phosphofructokinase, platelet
|
Kinase
|
8.8E-25 |
0.760 |
0.346 |
MOB4 |
Q9Y3A3
|
MOB family member 4, phocein
|
Enzyme modulator
|
0.93 |
0.751 |
0.346 |
REG4 |
Q9BYZ8
|
regenerating family member 4
|
|
7.5E-04 |
0.615 |
0.385 |
H2AZ1 |
P0C0S5
|
H2A.Z variant histone 1
|
|
0.88 |
0.674 |
0.385 |
PTP4A1 |
Q93096
|
protein tyrosine phosphatase 4A1
|
|
0.28 |
0.711 |
0.385 |
LOC110283621 |
|
SPP1 5' regulatory region
|
|
|
0.743 |
0.385 |
VASH1 |
Q7L8A9
|
vasohibin 1
|
|
0.33 |
0.601 |
0.423 |
TRIM44 |
Q96DX7
|
tripartite motif containing 44
|
|
5.4E-02 |
0.612 |
0.423 |
VTA1 |
Q9NP79
|
vesicle trafficking 1
|
|
4.0E-04 |
0.641 |
0.423 |
HCC |
|
thyroid carcinoma, Hurthle cell
|
|
|
0.644 |
0.423 |
HHLA2 |
Q9UM44
|
HERV-H LTR-associating 2
|
Enzyme modulator
|
1.7E-06 |
0.653 |
0.423 |
MIR605 |
|
microRNA 605
|
|
|
0.644 |
0.423 |
CBLB |
Q13191
|
Cbl proto-oncogene B
|
Enzyme
|
1.00 |
0.691 |
0.423 |
IMP3 |
Q9NV31
|
IMP U3 small nucleolar ribonucleoprotein 3
|
Nucleic acid binding
|
1.5E-07 |
0.566 |
0.462 |
EBAG9 |
O00559
|
estrogen receptor binding site associated antigen 9
|
|
7.7E-02 |
0.615 |
0.462 |
ANXA10 |
Q9UJ72
|
annexin A10
|
|
9.6E-14 |
0.621 |
0.462 |
PTPN3 |
P26045
|
protein tyrosine phosphatase non-receptor type 3
|
|
6.7E-09 |
0.647 |
0.462 |
ROBO2 |
Q9HCK4
|
roundabout guidance receptor 2
|
|
1.00 |
0.633 |
0.462 |
KLHL2 |
O95198
|
kelch like family member 2
|
|
1.00 |
0.751 |
0.462 |
CCAT1 |
|
colon cancer associated transcript 1
|
|
|
0.585 |
0.500 |
NEK8 |
Q86SG6
|
NIMA related kinase 8
|
Kinase
|
6.5E-09 |
0.631 |
0.500 |
MUC13 |
Q9H3R2
|
mucin 13, cell surface associated
|
|
2.4E-03 |
0.633 |
0.500 |
SHMT2 |
P34897
|
serine hydroxymethyltransferase 2
|
Enzyme
|
7.8E-08 |
0.621 |
0.500 |